Visionflex faces liquidity pressure as ARR falls 25%

Cash falls to A$657,000 as funding runway narrows

Visionflex Group Limited (ASX:VFX) finished the September quarter with A$657,000 in cash after burning A$860,000 on operations, leaving the medical technology company with estimated funding for 2.1 quarters at the reported rate. It also had A$1.15 million in undrawn facilities, taking total available funding to A$1.807 million, although that capacity includes interest-bearing debt and an R&D-backed loan rather than cash on hand.

The quarter’s cash position was pressured by A$1.8 million of operating and administration payments against A$893,000 of customer receipts. Visionflex repaid A$100,000 of borrowings during the period, while its cash balance fell from A$1.622 million at the end of June. That is a sharp reversal from the positive operating cash flow in Q4 FY26, which had briefly offered a more favourable cash-flow signal.

Aged care exits drive 25% ARR decline

Annual Recurring Revenue fell to approximately A$1.47 million at 30 September, down 25% from both 30 June and the prior corresponding period under the company’s reported definition. The largest movement came from 80 PHN-funded aged care facilities that did not move to paid subscriptions after their initial funding periods ended, removing A$260,000 of ARR.

A further A$170,000 was lost from privately funded aged care facilities and groups whose subscriptions expired without confirmed renewal. The company also attributed A$90,000 of the decline to the non-renewal of a legacy Western NSW Local Health District support contract for older mobile devices. Visionflex said retention varied according to facility utilisation, and that the aged care transition would continue into the December quarter.

The company has revised the way it counts expired subscriptions, excluding contracts without a confirmed renewal. On that like-for-like basis, September ARR was materially consistent with the revised June balance of A$1.46 million, but remained 23% below the restated prior-year figure. The change in definition softens the quarter-on-quarter comparison, not the underlying loss of subscriptions recorded during the period.

Hardware wins need to become recurring contracts

Revenue rose 3% to A$0.9 million, but only about 40% was recurring in nature, down from 49% a year earlier. New contracts worth A$300,000 were secured across workplace emergency response, resources, a United States channel and Aboriginal community controlled health, yet aged care contributed just 1% of that total and most of the contracts were hardware-led.

Fire and Safety Australia ordered two carts for A$84,000, ePlus Technology ordered 18 examination cameras for A$60,000, and Aspen Medical added a cart for an Origin Energy facility for A$34,000. Visionflex also reported subscription renewals from Kimberley Aboriginal Medical Service, Respect Group and Woodside Energy, alongside post-quarter orders from Puntukurnu Aboriginal Medical Service and Murray PHN. The commercial test is whether these deployments generate durable subscriptions rather than one-off equipment revenue.

RFDS expansion offers a near-term revenue catalyst

Delivery of the Royal Flying Doctor Service South Australia and Northern Territory network expansion has moved into November 2026 from the previously expected September quarter. Visionflex expects to recognise A$200,000 of revenue from FY26 RFDS contracts when the project is delivered, while contract liabilities stood at A$1.1 million at quarter-end.

The RFDS work also includes the company’s unattended access capability, which was previously launched alongside the RFDS SA/NT deployment. A supervised virtual emergency care trial involving Northern Territory pastoral stations, NT Health and the NT Cattlemen’s Association may give participating stations a route to direct subscriptions after the trial, but the filing does not quantify any resulting revenue.

Debt capacity carries a meaningful cost

Visionflex’s remaining funding includes A$950,000 available under an unsecured convertible note facility with Adcock Private Equity, an entity associated with chair Brook Adcock. The facility carries interest at 12.1% based on the rate disclosed at quarter-end, plus a 1% annual line fee, and includes provisions allowing part of existing debt to convert into shares.

A separate A$600,000 R&D facility had A$400,000 drawn and carries interest at 16.5%. Visionflex expects to receive an R&D tax incentive refund of approximately A$576,000 in the December quarter and use it to repay the drawn balance and accrued interest. The resulting cash relief would help, but it would not by itself resolve the gap between current operating burn and recurring revenue.